Exhibit 99.1 INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights PLYMOUTH MEETING, PA – May 13, 2025 – INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2025 and provided an update on recent company developments. "I'm pleased to confirm that we remain on track to submit ou ...